Aerobic exercise prescription in patients with chronic heart failure: a review in the beta-blocker era

被引：3
|
作者：
Carvalho, Vitor Oliveira [1 ]
机构：
[1] USP InCor HC FMUSP, Unidade Cirurgia Cardiaca Pediat, Inst Coracao, Hosp Clin,Fac Med, BR-05403900 Sao Paulo, Brazil
来源：
JOURNAL OF CARDIOVASCULAR MEDICINE | 2012年 / 13卷 / 09期
关键词：
beta-blockers; carvedilol; exercise; heart failure; rehabilitation; OXYGEN-UPTAKE; RATE RESERVE; CARVEDILOL;
D O I：
10.2459/JCM.0b013e328356a3b2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Aerobic exercise training is a well-established nonpharmacological tool in patients with clinically stable chronic heart failure. In recent years, beta-blocker therapy has become a primary pharmacologic intervention in patients with chronic heart failure. Despite the undeniable improvements in patients, the beta-blocker era has aroused uncertainties about aerobic exercise intensity prescription. It is well known that aerobic exercise prescription is performed by a percentage of the patient's heart rate reserve and the use of beta-blockers could interfere in this method. For this reason, the aim of this review is to provide an update about aerobic exercise prescription in patients with chronic heart failure who are using beta-blockers.
引用
收藏
页码：570 / 574
页数：5
相关论文
共 50 条
  • [21] Beta-Blocker Use at Discharge in Patients Hospitalized for Heart Failure Is Associated With Improved Survival
    Tsuchihashi-Makaya, Miyuki
    Kinugawa, Shintaro
    Yokoshiki, Hisashi
    Hamaguchi, Sanae
    Yokota, Takashi
    Goto, Daisuke
    Goto, Kazutomo
    Takeshita, Akira
    Tsutsui, Hiroyuki
    CIRCULATION JOURNAL, 2010, 74 (07) : 1364 - 1371
  • [22] beta-blocker in Heart failure with reduced ejection fraction: A review
    Adhikari, Chandra Mani
    NEPALESE HEART JOURNAL, 2013, 10 (01) : 38 - 45
  • [23] Inotropes in the beta-blocker era
    Lowes, BD
    Simon, MA
    Tsvetkova, TO
    Bristow, MR
    CLINICAL CARDIOLOGY, 2000, 23 (03) : 11 - 16
  • [24] Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker?
    Guo, Yong-Fang
    An, Yi
    JOURNAL OF GERIATRIC CARDIOLOGY, 2011, 8 (04) : 260 - 262
  • [25] Changes in collagen metabolism account for ventricular functional recovery following beta-blocker therapy in patients with chronic heart failure
    Fukui, Miho
    Goda, Akiko
    Komamura, Kazuo
    Nakabo, Ayumi
    Masaki, Mitsuru
    Yoshida, Chikako
    Hirotani, Shinichi
    Lee-Kawabata, Masaaki
    Tsujino, Takeshi
    Mano, Toshiaki
    Masuyama, Tohru
    HEART AND VESSELS, 2016, 31 (02) : 173 - 182
  • [26] Is Target Dose of Beta-Blocker More Important Than Achieved Heart Rate or Heart Rate Change in Patients with Systolic Chronic Heart Failure?
    Porapakkham, Pornwalee
    Porapakkham, Pramote
    Krum, Henry
    CARDIOVASCULAR THERAPEUTICS, 2010, 28 (02) : 93 - 100
  • [27] Trends and inequities in beta-blocker prescribing for heart failure
    Shah, Sunil M.
    Carey, Iain M.
    DeWilde, Stephen
    Richards, Nicky
    Cook, Derek G.
    BRITISH JOURNAL OF GENERAL PRACTICE, 2008, 58 (557): : 862 - 869
  • [28] Beta-blocker benefit according to severity of heart failure
    Bouzamondo, A
    Hulot, JS
    Sanchez, P
    Lechat, P
    EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (03) : 281 - 289
  • [29] Which Beta-Blocker is Most Effective in Heart Failure?
    Remme, Willem J.
    CARDIOVASCULAR DRUGS AND THERAPY, 2010, 24 (04) : 351 - 358
  • [30] Principles of exercise prescription for patients with chronic heart failure
    Jonathan Myers
    Heart Failure Reviews, 2008, 13 : 61 - 68
12345